iCAD, a global medical technology leader providing innovative enhanced cancer detection and therapy solutions for more than 6,000 facilities worldwide, offers a wide range of powerful tools for clinicians to support cancer detection, while enhancing workflow efficiency. iCAD’s Breast Health Solutions include the ProFound AI platform, a high-performing, concurrent-read workflow solution built on the latest deep-learning artificial intelligence that rapidly analyzes 2D mammography images or tomosynthesis slices to detect malignant soft tissue densities and calcifications with unrivaled accuracy, and PowerLook Density Assessment, which assists radiologists in determining the patient’s appropriate breast density category. This powerful platform is scalable for new applications, including ProFound AI Risk, the first commercially available clinical decision support tool that uniquely combines age, breast density, the presence of masses and calcifications and their asymmetry, resulting in a highly accurate short-term risk estimation that is truly personalized for each woman. For more information, visit www.icadmed.com.



Events not available


IMAGING Management

Improving Breast Cancer Detection with ProFound AI for 2D Mammography

2020 15 Jul

According to the International Agency for Research on Cancer, in 2018 breast cancer accounted for 26.4 percent of all new cancer cases in European women. [i]  Europe’s radiologist shortage, particularly in Scotland and the United Kingdom, where the shortage is dire, makes it hard to maintain medical standards. [ii]  Without a sufficient number... Read more

Jobs not available


    Catalogue not available

98 Spit Brook Rd Suite 100,
United States
(603) 882-5200

White Papers - Case Studies

IMAGING Management

Private German Radiology Practice Improves Workflow and Speeds Breast Cancer Diagnostics

2020 19 May

“ iCAD ’s ProFound AI ™ solution has had a significant impact on our workflow. We are able to  immediately react if we see something suspicious in a scan alleviating anxiety for our patients. Using the solution will allow us to expand DBT beyond diagnosis because it enables our radiologists to read as many tomosynthesis cases as we... Read more

IMAGING Management

Swedish-American Hospital Adopts PowerLook® Density Assessment

2020 19 May

“Installing PowerLook ® Density Assessment has helped improve the workflow of our department and also in the education of our patients about the importance of knowing your breast density,” Adrea Bennett, Center for Women Supervisor, Swedish-American Hospital Summary Swedish-American Hospital (SAH), a division of UW Health,... Read more

IMAGING Management

Artificial Intelligence for Digital Breast Tomosynthesis - Reader Study Results

2020 19 May

Abstract ProFound AI™ is the latest artificial intelligence algorithm developed by iCAD , Inc., Nashua, NH using deep learning technology that is intended to be used concurrently by radiologists while reading digital breast tomosynthesis (DBT) exams. The algorithm detects soft tissue densities (masses, architectural distortions and asymmetries)... Read more



Not available